Segmentation, Targeting and Positioning

Introduction

Healthcare markets are heterogeneous. Patients differ in age, income, location, health status, risk exposure, digital access, cultural expectations, willingness to pay, and preferred care pathways. Providers also serve referrers, employers, insurers, governments, caregivers, and communities. A hospital that attempts to appeal equally to everyone may communicate weakly, allocate resources inefficiently, and create a service experience that satisfies no clearly defined group.

Segmentation, targeting and positioning (STP) provide a disciplined approach to this problem. Segmentation divides a broad market into meaningful groups with relatively similar needs or responses. Targeting evaluates those groups and selects one or more for strategic attention. Positioning establishes the distinctive place a healthcare organisation, service, or programme seeks to occupy in the minds of its priority stakeholders.

In healthcare, STP cannot be treated as a purely commercial exercise. It must be reconciled with clinical appropriateness, equity, informed choice, privacy, professional ethics, public health responsibilities, and regulation. The central managerial question is therefore not simply “Which patients are most profitable?” but “Which populations can we serve well, ethically, sustainably, and with a differentiated value proposition?”

Learning Objectives

By the end of this chapter, the reader should be able to:

1. Explain the meaning and strategic role of segmentation, targeting and positioning in healthcare services.
2. Apply demographic, geographic, psychographic, behavioural, clinical and value-based segmentation.
3. Assess segment attractiveness using demand, strategic fit, operational feasibility, financial contribution, equity and ethical criteria.
4. Select appropriate target-market strategies for healthcare organisations.
5. Develop defensible positioning statements and healthcare value propositions.
6. Evaluate the limitations, ethical risks and governance requirements of STP, including the use of data and artificial intelligence.

1. The Logic of STP in Healthcare Services

STP is a linked decision process rather than three independent activities:

Segmentation → Targeting → Positioning → Service design and delivery → Measurement and refinement

Segmentation identifies differences that matter. Targeting determines where organisational resources should be concentrated. Positioning translates the selected strategy into a credible promise for patients and other stakeholders. The promise must then be supported by actual service processes, clinical outcomes, employee behaviour, access arrangements and evidence.

A healthcare position is defensible only when it is:

• Relevant: it addresses an important patient or stakeholder need.
• Distinctive: it is meaningfully different from alternatives.
• Credible: the organisation possesses evidence and capabilities to support it.
• Consistent: communications, clinical processes and patient experience reinforce it.
• Sustainable: competitors cannot easily copy it, or the organisation can continually renew it.
• Ethically acceptable: it does not exploit vulnerability or undermine equitable access.

Healthcare services are intangible, variable, inseparable from delivery, and often difficult to evaluate before use. Consequently, positioning must include both functional benefits—such as shorter waiting time, diagnostic accuracy or continuity of care—and emotional or relational benefits, such as trust, dignity, reassurance and respect.

2. Market Definition Before Segmentation

A segmentation study begins by defining the relevant market. A market may be defined narrowly, such as “private outpatient cardiac rehabilitation within a metropolitan region,” or broadly, such as “services that help adults manage cardiovascular risk.” The definition should identify:

• the need being addressed;
• the population experiencing the need;
• substitute solutions, including self-care and digital services;
• the geographic and regulatory boundaries;
• the payer or financing arrangement; and
• the decision maker, user and beneficiary.

These roles may differ. An employer may purchase an occupational health programme, an employee may use it, and an insurer may pay for it. In paediatrics, a parent commonly makes the appointment decision while the child receives the service. In chronic disease management, a clinician may influence selection while the patient experiences the programme. Segment analysis should therefore distinguish the user, payer, influencer, decision maker and beneficiary.

A useful market definition also considers the patient journey: awareness, information search, referral, appointment, treatment, recovery, follow-up and advocacy. Different segments may emerge at different stages. For example, digitally confident patients may prefer online scheduling, whereas older patients may value telephone support even when both groups require the same clinical treatment.

3. Bases of Healthcare Segmentation

3.1 Demographic segmentation

Demographic variables include age, sex, gender identity, family composition, education, occupation, income and socioeconomic status. They are widely available and useful for estimating service demand. Examples include antenatal services for women in a defined age range, occupational health for industrial employees, and geriatric services for older adults.

Demographics should not be treated as automatic proxies for need. Age may correlate with prevalence of a condition, but individuals of the same age differ substantially in health status, preferences and access barriers. Gender categories must be used respectfully and should not erase transgender and non-binary populations. Income can indicate ability to pay, but using it carelessly may create discriminatory exclusion.

3.2 Geographic segmentation

Geographic segmentation uses residence, travel time, urban or rural location, climate, transport availability, service catchment area and population density. It is particularly important because healthcare consumption is constrained by distance, mobility and local supply.

Geographic analysis may identify rural populations needing mobile clinics, urban workers requiring evening appointments, or communities underserved by public transport. Contemporary geographic information systems can combine population data, travel-time estimates and facility capacity. However, maps must be interpreted cautiously: an apparently nearby facility may be inaccessible because of cost, disability, language, safety or cultural concerns.

3.3 Psychographic segmentation

Psychographic segmentation examines lifestyles, values, attitudes, health beliefs, risk perceptions, personality and preferences. Two patients with similar clinical profiles may differ in their desire for autonomy, technology, family involvement or complementary care.

Examples include:

• prevention-oriented consumers who actively monitor health;
• reassurance seekers who require extensive explanation;
• convenience-oriented users who value rapid digital access; and
• socially motivated patients who prefer peer support.

Psychographic data can improve communication and service design, but sensitive inferences should not be made without appropriate consent and safeguards. A patient’s reluctance to use technology may reflect disability or lack of access rather than a stable “personality type.”

3.4 Behavioural segmentation

Behavioural variables include service usage, appointment patterns, adherence, referral source, channel preference, readiness to change, response to communication, loyalty and benefit sought. Behaviour often predicts service requirements more directly than demographics.

For example, a diabetes programme may distinguish newly diagnosed patients, patients with repeated missed appointments, patients with stable control, and patients at high risk of complications. Each group may require a different intensity and channel of support. Behavioural segmentation should avoid labelling patients morally. Non-adherence may arise from cost, transport, side effects, health literacy or fragmented services.

3.5 Clinical segmentation

Clinical segmentation uses diagnosis, disease severity, risk level, comorbidity, treatment pathway, acuity, functional status and expected care needs. It is central to population health management and integrated care.

Examples include:

• low-, medium- and high-risk hypertension populations;
• elective versus emergency surgical patients;
• patients with uncomplicated versus complex diabetes; and
• individuals requiring prevention, early intervention, maintenance or palliative care.

Clinical segmentation must use validated definitions, current data and multidisciplinary review. It should support appropriate care rather than reduce people to diagnoses. Clinical risk scores are aids to judgement, not substitutes for professional assessment.

3.6 Value-based segmentation

Value-based segmentation considers the relationship between outcomes, experience, cost and resources. In a healthcare context, value is not identical to revenue. A practical expression is:

“Outcomes” may include survival, functional improvement, symptom control, safety and patient-reported quality of life. “Total cost” includes clinical resources, administration, complications, avoidable utilisation and, where relevant, patient time and travel. The expression is conceptual rather than a universal accounting formula; organisations must define outcomes, costs, time horizons and population boundaries consistently.

Value-based segmentation may identify patients for whom coordinated intervention can substantially improve outcomes, populations with high avoidable emergency use, or services where a redesigned pathway can reduce cost without reducing quality. It must not be used to abandon patients whose care is complex or expensive. Equity and duty of care constrain value-based decisions.

3.7 Firmographic and stakeholder segmentation

For business-to-business healthcare, organisations may be segmented by size, industry, payer type, procurement process, clinical capability, budget, risk profile and partnership objectives. Hospitals may segment referring physicians by specialty, referral volume and information needs, while suppliers may segment provider organisations by technology maturity and purchasing governance.

4. Designing Useful Segments

A segment is strategically useful when it is sufficiently homogeneous internally and sufficiently different from other segments in needs or likely response. Traditional criteria are:

These criteria are not absolute. A small segment may be strategically important if it has severe unmet need or supports a statutory responsibility. A segment that is easy to measure may still be unsuitable if the data are biased or the category is clinically meaningless.

Combining segmentation variables

Single-variable segmentation is often inadequate. A useful segment profile may combine clinical need, behaviour, geography and access barriers. For instance: “Adults with uncontrolled type 2 diabetes, living more than 30 minutes from a specialist clinic, who have missed at least two appointments in six months and prefer telephone contact.” This description suggests both a need and an intervention design.

Organisations should avoid excessive micro-segmentation. If every patient becomes a unique segment, the framework cannot guide resource allocation. Segments should be sufficiently broad to support scalable service design while allowing reasonable personalisation.

5. Evaluating Segment Attractiveness

Segment attractiveness requires a balanced evaluation of external opportunity and organisational capability. Important questions include:

1. Need and potential impact: How serious is the unmet need? Can the organisation improve meaningful outcomes?
2. Size and growth: How many people are included, and how may prevalence or demand change?
3. Competitive intensity: Which providers already serve the segment, and how strong are substitutes?
4. Economic sustainability: What are expected revenues, costs, payment arrangements and contribution margins?
5. Strategic fit: Does the segment match the mission, brand, capabilities and partnerships of the organisation?
6. Operational feasibility: Are staff, facilities, technology, referral networks and capacity available?
7. Risk and regulation: Are there clinical, legal, reputational or data risks?
8. Equity: Would prioritisation improve or worsen disparities?
9. Stakeholder acceptability: Do patients, clinicians, payers and community partners support the approach?

A structured scoring matrix can make assumptions explicit. For example, managers may rate each segment from 1 to 5 on need, strategic fit, feasibility, financial sustainability and equity, then assign weights. A weighted score can be calculated as:

where S_j is the score for segment j, w_i is the weight assigned to criterion i, and r_ij is the rating of segment j on criterion i. Weights should sum to 1, and ratings must use the same scale. The score supports discussion; it does not replace clinical, ethical or board-level judgement.

Worked example

An integrated care provider compares two illustrative segments. Weights are need and impact 0.30, strategic fit 0.20, feasibility 0.20, financial sustainability 0.15 and equity 0.15. Ratings use a 1–5 scale.

For Segment A, the score is (0.30×5)+(0.20×4)+(0.20×3)+(0.15×3)+(0.15×5)=4.05. Segment B scores (0.30×3)+(0.20×5)+(0.20×4)+(0.15×5)+(0.15×2)=3.80. Segment A ranks higher because its need and equity contribution offset lower feasibility and financial sustainability. Managers should then test the assumptions through pilot implementation rather than treating 4.05 as an objective truth.

6. Targeting Strategies

Undifferentiated targeting

The organisation offers a broadly standardised service to the whole market. This may be appropriate for universal vaccination, emergency access or basic preventive information, where broad reach is essential. Its weakness is limited responsiveness to different needs.

Differentiated targeting

The organisation selects several segments and designs a distinct service or communication approach for each. A health system might provide separate pathways for low-risk, complex and frail patients. Differentiation can improve relevance but increases operational complexity and cost.

Concentrated or niche targeting

The organisation focuses resources on one or a small number of segments. A specialist cancer centre is an example. Niche targeting can create deep expertise and strong positioning, but it increases exposure to changes in referral patterns, regulation or demand.

Micromarketing and personalisation

Services are adapted to local populations or individuals. Personalised reminders, risk-based outreach and tailored rehabilitation plans are examples. Personalisation should be clinically justified, transparent and inclusive; it should not become covert discriminatory pricing or exclusion.

Social and public-health targeting

Public-health programmes may prioritise populations according to risk, vulnerability and potential population benefit rather than purchasing power. This approach recognises that the most important target is not always the most commercially attractive one.

Target-market selection may also be staged. An organisation may pilot a service with one segment, evaluate outcomes and then expand. This reduces risk and generates evidence about operational fit.

7. Positioning and Value Propositions

Positioning is the intended meaning of an offering relative to alternatives. It is not merely a slogan or logo. A positioning decision answers four questions:

• For whom is the service designed?
• What important problem does it solve?
• What distinctive benefit does it provide?
• Why should stakeholders believe the claim?

A practical positioning statement is:

For [priority segment], [service or organisation] is the [category or frame of reference] that provides [distinctive benefit], because [reasons to believe].

For example: “For adults living with complex diabetes in the regional catchment, the Integrated Diabetes Partnership is the coordinated care pathway that helps patients achieve safer, more manageable daily care because it combines specialist review, primary-care coordination, remote monitoring and educator support.” This statement identifies the segment, category, benefit and evidence base without promising an outcome that cannot be guaranteed.

Points of parity and points of difference

A provider must first meet points of parity: safety, professional competence, privacy, accessibility and regulatory compliance. Points of difference may include continuity, culturally responsive care, speed, advanced expertise, integrated coordination, transparent pricing or superior patient-reported outcomes.

A claimed difference is valuable only if patients care about it and competitors cannot easily neutralise it. “High quality” is usually too broad to position effectively unless quality is defined and demonstrated through evidence.

Value propositions in healthcare

A value proposition integrates benefits, costs and experience for a defined stakeholder. It may include:

• clinical outcomes and safety;
• access and convenience;
• emotional reassurance and dignity;
• coordination and reduced administrative burden;
• financial predictability;
• support for self-management; and
• benefits to caregivers, employers or payers.

The organisation should distinguish the promised value from realised value. Promised value is communicated before use; realised value is experienced and measured after delivery. Gaps between the two create dissatisfaction, distrust and reputational risk.

8. Implementing and Measuring Positioning

Positioning must be embedded in the service system. If an organisation positions itself around “continuity,” patients should encounter stable clinical teams, accessible records, planned follow-up and reliable communication. If it positions itself around “rapid access,” appointment capacity, triage, diagnostic workflows and escalation processes must support the claim.

Measurement should combine market, operational, clinical and experience indicators:

A useful evaluation design compares performance with a baseline or appropriate comparator and examines results by segment. Aggregate averages can conceal inequity: an organisation may improve overall satisfaction while worsening outcomes for people with limited English proficiency or disabilities.

9. Illustrative Case: The Northbridge Integrated Respiratory Service

Background

Northbridge is a fictional regional health system serving urban and rural communities. Its emergency departments report repeated attendances by adults with chronic obstructive pulmonary disease (COPD). Patient interviews reveal fragmented follow-up, uncertainty about inhaler use, transport barriers and limited confidence in recognising deterioration.

Problem

The existing service is organised around clinic appointments rather than patient needs. Marketing materials describe “specialist respiratory excellence,” but the claim does not address the practical problems experienced between appointments. Attendance is particularly poor among rural patients and people with unstable employment.

Analysis

The team combines clinical and behavioural data to create preliminary segments:

1. stable patients needing prevention and self-management;
2. recently discharged patients at high risk of readmission;
3. patients with repeated emergency attendance and complex comorbidity; and
4. rural patients facing transport and access barriers.

Interviews add psychographic and access information. Some patients prefer telephone coaching, while others value a digital monitoring option. Clinicians identify medication reconciliation and early escalation as important clinical requirements.

Approach

The service selects segments 2–4 for an initial targeted programme because potential clinical impact is high and the organisation has relevant nursing and primary-care capabilities. The value proposition is: “Coordinated respiratory support that helps people remain safely at home through timely follow-up, inhaler coaching and rapid escalation when symptoms worsen.”

The service introduces post-discharge calls, pharmacist-led inhaler review, a rural telephone pathway, transport coordination and a clinician escalation protocol. Digital monitoring is offered but not required. Communications use plain language and are available through translated and accessible formats.

Outcome

After a pilot period, the organisation evaluates readmissions, emergency attendance, patient-reported confidence, follow-up completion, staff workload and outcomes by geography and language. The pilot is not judged solely by enrolment or revenue. If readmissions do not improve, the team investigates clinical appropriateness, implementation fidelity and barriers before changing the position or abandoning the programme.

Learning points

The case illustrates that clinical segmentation is strengthened by behavioural and geographic insight. It also shows that positioning must describe a deliverable pathway rather than a vague quality claim. Finally, inclusive design protects the service from confusing digital convenience with universal accessibility.

10. Ethics, Governance and Regulation

Healthcare segmentation involves sensitive personal data. Organisations should apply data minimisation, purpose limitation, secure storage, access controls, retention rules and lawful processing. Patients should receive understandable information about how their data are used, particularly when data support marketing or automated decisions.

Key ethical risks include:

• Discrimination: targeting or deprioritising groups on the basis of protected or proxy characteristics.
• Exploitation of vulnerability: using fear, illness or uncertainty to create inappropriate demand.
• Inadequate consent: treating clinical data as unrestricted marketing data.
• Opacity: hiding eligibility rules, prices or limitations.
• Digital exclusion: designing services that assume broadband, devices, literacy or physical ability.
• Misleading claims: presenting testimonials or outcomes that are unrepresentative.
• Conflicts of interest: allowing commercial incentives to distort clinical recommendations.

Governance should include clinical leadership, information-governance expertise, patient and community representation, equality review, model validation and monitoring for disparate impact. Segmentation should support access to appropriate care, not covertly rank human worth.

11. Technology, AI and Contemporary Developments

Customer relationship management systems, electronic health records, patient portals, geospatial analytics and remote monitoring can make segmentation more timely. Machine-learning models may identify patients at risk of deterioration or non-attendance, but predictive accuracy alone does not establish fairness or usefulness.

Before deploying an AI-supported segmentation system, managers should ask:

1. Is the target outcome clinically meaningful?
2. Are the training data representative of the intended population?
3. Are labels and outcomes measured consistently?
4. Does performance vary across demographic, geographic or clinical groups?
5. Can clinicians and patients understand and challenge the result?
6. Will an intervention actually be available after a person is identified?
7. Are privacy, security, consent and accountability arrangements adequate?

A prediction without an effective intervention may merely classify disadvantage. Human oversight, prospective evaluation, version control and continuous bias monitoring are therefore essential.

Contemporary positioning is also shaped by consumerisation, virtual care, value-based payment, patient-generated data, integrated care and social determinants of health. These developments increase the importance of designing propositions around outcomes and life context rather than around isolated clinical departments.

12. Challenges and Limitations

STP can oversimplify complex identities and changing needs. Patients may move between segments as their condition, income, location or confidence changes. Data may be incomplete, outdated or systematically missing for marginalised groups. Financial measures may privilege easily monetised services over prevention or community benefit. Competitor analysis may encourage imitation rather than genuine innovation.

There is also a tension between standardisation and personalisation. Standardised pathways improve reliability and safety, while personalisation can improve relevance. The appropriate balance depends on clinical risk, patient preference, operational capability and evidence. Segment definitions should therefore be reviewed periodically, tested with qualitative insight and linked to measurable service decisions.

Best practice is to triangulate sources: administrative data, clinical evidence, patient-reported information, interviews, community consultation, competitor analysis and frontline staff knowledge. A segment is a managerial model of reality, not reality itself.

Best-Practice Guidelines

1. Begin with patient and population needs, not available promotional channels.
2. Define the market and stakeholder roles before collecting data.
3. Combine clinical, behavioural, geographic and access variables where relevant.
4. Use validated clinical definitions and transparent segment rules.
5. Evaluate attractiveness using impact, feasibility, sustainability and equity.
6. Select targets that the organisation can genuinely serve well.
7. Make positioning specific, evidence-based and operationally deliverable.
8. Treat patient experience and clinical outcomes as central components of value.
9. Provide non-digital alternatives when digital access is unequal.
10. Test claims through pilots and monitor outcomes by segment.
11. Apply privacy, equality and information-governance safeguards.
12. Reassess segments as evidence, demand and community needs change.

Chapter Summary

Segmentation, targeting and positioning provide a strategic framework for managing heterogeneous healthcare markets. Segmentation may use demographic, geographic, psychographic, behavioural, clinical, value-based and stakeholder variables. Effective segments are measurable, substantial, accessible, differentiable, actionable and ethically permissible, although these criteria must be interpreted in relation to public-health responsibilities and equity.

Targeting involves selecting segments according to need, potential impact, strategic fit, feasibility, financial sustainability, competition, risk and fairness. Organisations may use undifferentiated, differentiated, concentrated or personalised strategies. Positioning defines the distinctive meaning an organisation seeks to establish for a priority segment. A credible value proposition links relevant benefits to evidence and operational capability.

In healthcare, STP is constrained by clinical duty, privacy, regulation and the risk of discrimination. Technology and AI can improve insight but require validation, transparency, human oversight and monitoring for inequitable effects. Ultimately, successful STP is demonstrated not by attractive messaging alone but by improved outcomes, experience, access and sustainable value for the populations served.

Key Terms

Segmentation: Dividing a heterogeneous market into groups with relatively similar needs or responses.

Targeting: Evaluating segments and selecting those for strategic attention.

Positioning: Establishing a desired and distinctive place for an offering in stakeholder perceptions.

Value proposition: A statement of benefits and value offered to a defined stakeholder group.

Demographic segmentation: Grouping by characteristics such as age, income, education or occupation.

Geographic segmentation: Grouping by location, travel time, catchment or access conditions.

Psychographic segmentation: Grouping by values, lifestyles, attitudes and beliefs.

Behavioural segmentation: Grouping by usage, adherence, channel preference or response patterns.

Clinical segmentation: Grouping by diagnosis, severity, risk, acuity or care need.

Value-based segmentation: Grouping in relation to outcomes, experience, cost and resource use.

Segment attractiveness: The extent to which a segment offers need, impact, feasibility and strategic opportunity.

Points of parity: Minimum attributes required to be considered a legitimate alternative.

Points of difference: Distinctive attributes that create preference relative to alternatives.

Patient-reported outcome: A health outcome reported directly by the patient.

Patient-reported experience: The patient’s account of how care was accessed and delivered.

Micromarketing: Adaptation of services to local or individual circumstances.

Equity: Fairness in access, treatment, outcomes and distribution of health opportunity.

Disparate impact: An unjustifiably unequal effect of a policy or model on a particular group.

Market positioning statement: A structured statement identifying the target, category, benefit and reasons to believe.

Review Questions

Short Answer Questions

1. Define segmentation, targeting and positioning, and explain how they are connected.
2. Distinguish demographic segmentation from clinical segmentation.
3. State five criteria for evaluating a healthcare market segment.
4. What is the difference between a point of parity and a point of difference?
5. Why must a healthcare value proposition include evidence and operational capability?

Long Answer Questions

1. Explain how an integrated healthcare provider could combine geographic, behavioural and clinical segmentation to redesign a chronic disease pathway.
2. Critically evaluate differentiated targeting in comparison with concentrated targeting for a specialist hospital.
3. Discuss the relationship between positioning, patient experience and clinical outcomes.
4. Explain the ethical risks of using patient data for segmentation and propose governance safeguards.
5. Analyse why value-based segmentation should not be equated with selecting only the most profitable patients.

Analytical / Application Questions

1. A community clinic has high missed-appointment rates among rural patients. Develop a segment profile, recommend a target strategy and write a positioning statement.
2. Using the weighted-score method described in this chapter, design a five-criterion evaluation matrix for three potential healthcare segments. Justify the weights and explain the limitations of the result.
3. An AI model predicts which patients are likely to disengage from a digital care programme, but performance is lower for people with limited English proficiency. What managerial, ethical and operational actions should follow?

Multiple Choice Questions with Answers

Question 1

Which statement best describes healthcare segmentation?

A. Setting one price for every patient

B. Dividing a heterogeneous market into groups with relatively similar needs or responses

C. Promoting only the organisation’s most profitable service

D. Replacing clinical judgement with demographic data

Correct Answer: B. Dividing a heterogeneous market into groups with relatively similar needs or responses

Question 2

Which is an example of clinical segmentation?

A. Grouping patients by preferred social-media platform

B. Grouping patients by postal code only

C. Grouping patients by disease severity and care need

D. Grouping patients by advertising response only

Correct Answer: C. Grouping patients by disease severity and care need

Question 3

Which criterion asks whether an organisation can actually reach and serve a segment?

A. Accessibility

B. Differentiability

C. Substantiality

D. Stability

Correct Answer: A. Accessibility

Question 4

A point of difference is best described as:

A. A legally required minimum standard

B. A distinctive attribute that creates preference relative to alternatives

C. A patient’s diagnosis

D. A measure of market size

Correct Answer: B. A distinctive attribute that creates preference relative to alternatives

Question 5

Which targeting strategy concentrates resources on one or a small number of segments?

A. Undifferentiated targeting

B. Differentiated targeting

C. Concentrated targeting

D. Universal targeting

Correct Answer: C. Concentrated targeting

Question 6

In the weighted-score method, if weights are used as proportions, they should:

A. Sum to 1

B. Always be equal

C. Be negative for low-priority criteria

D. Be expressed only as percentages above 100

Correct Answer: A. Sum to 1

Question 7

Which statement about healthcare positioning is most accurate?

A. It is limited to a logo and slogan

B. It is the intended distinctive meaning of an offering relative to alternatives

C. It concerns only internal staff communication

D. It eliminates the need to measure outcomes

Correct Answer: B. It is the intended distinctive meaning of an offering relative to alternatives

Question 8

Which is an ethical risk of healthcare segmentation?

A. Improved continuity of care

B. More relevant service design

C. Discrimination through protected or proxy characteristics

D. Better monitoring of equity

Correct Answer: C. Discrimination through protected or proxy characteristics

Question 9

A value proposition should primarily connect:

A. A defined stakeholder’s needs with relevant, credible benefits

B. A competitor’s weaknesses with an untested promise

C. A diagnosis with a universal advertising message

D. Revenue targets with reduced clinical information

Correct Answer: A. A defined stakeholder’s needs with relevant, credible benefits

Question 10

Why does AI-supported segmentation require monitoring across population groups?

A. Because predictive models are always legally prohibited

B. Because performance and errors may differ across groups

C. Because human oversight is unnecessary

D. Because clinical outcomes cannot be measured

Correct Answer: B. Because performance and errors may differ across groups